These results are consistent with the finding that inhibition of PHLDA2 inhibits cell proliferation in vitro (Figure 2E–2H), suggesting that PHLDA2 promotes CRC progression in vivo and vitro. The gene discussed is PHLDA2; the disease is colorectal carcinoma.